About the Organization
UCB | Inspired by patients. Driven by Science.
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. By integrating biology (bio) and chemistry (pharma), we can gain much deeper insights into disease pathways, including the complexities of severe diseases, as well as producing more potent, cost-effective drugs. Severe diseases, such as epilepsy, Crohn's or Parkinson's, tend to be "silent diseases" - sufferers are often socially stigmatised and reluctant to share their experiences and insights. To overcome this problem, we are creating novel and personal ways for patients and their families to connect, virtually and live, with each other, us, our partners and opinion formers.